European Archives - Page 489 of 1334 - European Medical Journal

EMJ Nephrology 12.1 2024

In our latest issue of EMJ Nephrology, discover the latest in the field, featuring developments in antibody-mediated rejection…

SGLT2 Computational Structural Studies Investigating Polypharmacy

Widespread use of SLGT2 inhibitors (SGLT2i) is likely given recent recommendations for their use in chronic kidney disease and heart…

Review of the 61st European Renal Association (ERA) Congress

RETHINKING kidney health and transforming kidney care was the theme for the 61st European Renal Association (ERA) Congress…

Immune Complex-mediated MPGN Secondary to Primary Biliary Cholangitis

Immune complex-mediated membranoproliferative glomerulonephritis (iMPGN) can develop in association with autoimmune diseases such as…

Characteristics, Humanistic Burden, and Kidney Outcomes in Immunoglobulin A Nephropathy

IgAN is an immune-complex mediated glomerular disease with an incidence rate of 0.03−10.5/100,000 persons/year…

Potassium Intake on the Renoprotective Response in Patients with Diabetic Nephropathy

Salt restriction and hydrochlorothiazide (HCT) are known to increase the antihypertensive and antiproteinuric effects of…

Advancements in Glomerulonephritis Treatment

IgAN is a progressive, immune complex-mediated disease, and the most common primary glomerulonephritis, representing…

Challenges in Renal Replacement Therapy in Resource-Limited Settings

Chronic kidney disease (CKD) continues to be a global public health problem. Globally, the prevalence of CKD is approximately 8–16% in the…

Interaction of General Obesity and Abdominal Obesity, and Frailty in Patients with Chronic Kidney Disease

Chronic kidney disease (CKD) has become a major public health problem, affecting over 9.1% of adults globally. Frailty is marked…

End-Stage Renal Disease and Neurological Connection

Due to the incapacitating nature of end-stage renal disease, people on dialysis frequently acquire undetected psychopathological disorders.